Hanna Kim

9.1k total citations
119 papers, 3.2k citations indexed

About

Hanna Kim is a scholar working on Epidemiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Hanna Kim has authored 119 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 30 papers in Molecular Biology and 21 papers in Rheumatology. Recurrent topics in Hanna Kim's work include Inflammatory Myopathies and Dermatomyositis (20 papers), Eosinophilic Disorders and Syndromes (14 papers) and Dermatological and Skeletal Disorders (6 papers). Hanna Kim is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (20 papers), Eosinophilic Disorders and Syndromes (14 papers) and Dermatological and Skeletal Disorders (6 papers). Hanna Kim collaborates with scholars based in United States, South Korea and Canada. Hanna Kim's co-authors include Akira Chiba, Raphaela Goldbach‐Mansky, Gina A. Montealegre Sanchez, Roy Kornbluh, T. S. Low, Harsha Prahlad, Massimo Gadina, A. Wong-Foy, Ron Pelrine and Joseph Eckerle and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Neuroscience.

In The Last Decade

Hanna Kim

108 papers receiving 3.1k citations

Peers

Countries citing papers authored by Hanna Kim

Since Specialization

Citations

This map shows the geographic impact of Hanna Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Kim more than expected).

Fields of papers citing papers by Hanna Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Kim. The network helps show where Hanna Kim may publish in the future.

Co-authorship network of co-authors of Hanna Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Kim. A scholar is included among the top collaborators of Hanna Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Kim. Hanna Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers 2025 ·Lara D. Veeken ·(unknown), Rebecca Nicolai, (unknown), Silvia Rosina, (unknown), (unknown), Brigitte Bader‐Meunier, A. G. P. Brown, Marc H.A. Jansen, Susan Kim, Bianca Lang, Raquel Campanilho‐Marques, Liza McCann, Helga Sanner, Saskia R Veldkamp, Meredyth Wilkinson, (unknown), Hanna Kim, Stacey E. Tarvin, Charalampia Papadopoulou	1
2	MRI Coregistered Rodent Histotripsy Array for Orthotopic Liver Models 2025 ·IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control ·Ryan Hubbard, (unknown), Tejaswi Worlikar, Ulrich M. Scheven, Hanna Kim, Jonathan R. Sukovich, Timothy L. Hall, Zhen Xu	1
3	Monoclonal antibody targeting IFNβ for the treatment of NXP2-positive ulcerative juvenile dermatomyositis 2025 ·PEDIATRICS ·(unknown), Vignesh Ramachandran, Ruth Ann Vleugels, Steven A. Greenberg, Hanna Kim, Philip Kahn, Vikash S. Oza	3
4	DEVELOPMENT OF POSTPARTUM DEPRESSION FOLLOWING ASSISTED REPRODUCTIVE TECHNOLOGY: A LARGE NETWORK STUDY 2024 ·Fertility and Sterility ·(unknown), Hanna Kim, Elliott G. Richards	0
5	Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies 2024 ·Pediatric Drugs ·Hanna Kim	2
6	Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance 2023 ·Pediatric Rheumatology ·(unknown), Hanna Kim, (unknown), Amanda Brown, Harry L. Gewanter, Bianca Lang, (unknown), Angela Byun Robinson, (unknown), (unknown), Grant Syverson, (unknown), Charles H. Spencer, Stacey E. Tarvin	4
7	Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy 2023 ·Arthritis & Rheumatology ·Rodolfo Curiel, William Nguyen, Gulnara Mamyrova, (unknown), Alison Ehrlich, Kathleen A. Brindle, (unknown), (unknown), Hanna Kim, (unknown), Lisa G. Rider, (unknown)	14
8	Protein kinases: drug targets for immunological disorders 2023 ·Nature reviews. Immunology ·Leslie Castelo‐Soccio, Hanna Kim, Massimo Gadina, Pamela L. Schwartzberg, Arian Laurence, John J. O’Shea	64
9	AB5-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus 2023 ·Toxins ·(unknown), Ji Eun Yu, Hanna Kim, (unknown), Gyoonhee Han, Myung Hyun Sohn, Baik Lin Seong	3
10	Author Correction: Protein kinases: drug targets for immunological disorders 2023 ·Nature reviews. Immunology ·Leslie Castelo‐Soccio, Hanna Kim, Massimo Gadina, Pamela L. Schwartzberg, Arian Laurence, John J. O’Shea	0
11	Efficacy of topical ruxolitinib for cutaneous dermatomyositis 2023 ·JAAD Case Reports ·(unknown), Hanna Kim, Shajia Lu, Wanxia Li Tsai, (unknown), Alison Ehrlich, George M. Martin, Adam Schiffenbauer, Susan Shenoi	2
12	Association between long-term PM2.5 exposure and risk of Kawasaki disease in children: A nationwide longitudinal cohort study 2023 ·Environmental Research ·Hanna Kim, (unknown), (unknown), Whanhee Lee, Jongmin Oh, (unknown), Min Ho Kim, Jung Won Lee, Hae Soon Kim, Ho Kim, Ejin Kim, Cinoo Kang, In-Sung Song, (unknown), (unknown), Dohoon Kwon, (unknown), (unknown), (unknown), (unknown), Ayoung Kim, (unknown), (unknown), Eun‐Hee Ha	6
13	Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis 2023 ·Lara D. Veeken ·Melissa Morales, Tchilabalo Dilezitoko Alayi, (unknown), (unknown), (unknown), Hanna Kim, Kanneboyina Nagaraju, Yetrib Hathout, Lisa G. Rider	4
14	US ‐based and international environmental nongovernmental organizations use social media, but few have large audiences online 2023 ·Conservation Science and Practice ·Hanna Kim, Paul R. Armsworth, Yuta J. Masuda, Charlotte H. Chang	4
15	Coronin 1A depletion protects endothelial cells from TNFα-induced apoptosis by modulating p38β expression and activation 2015 ·Cellular Signalling ·Gi‐Young Kim, Hanna Kim, Hyun‐Joung Lim, Hyun‐Young Park	11
16	Hsp70 Interacts with the Retroviral Restriction Factor TRIM5α and Assists the Folding of TRIM5α 2010 ·Journal of Biological Chemistry ·Chae Young Hwang, Jens Holl, Devi Rajan, (unknown), Hanna Kim, Moonkyoung Um, Ki‐Sun Kwon, Byeongwoon Song	12
17	The Retinoic Acid Synthesis Gene ALDH1a2 Is a Candidate Tumor Suppressor in Prostate Cancer 2005 ·Cancer Research ·Hanna Kim, Jacques Lapointe, Gülşah Kaygusuz, David E. Ong, Chunde Li, Matt van de Rijn, James D. Brooks, Jonathan R. Pollack	110
18	Hamiltonian Paths in Projective Checkerboards. 2000 ·Ars Combinatoria ·(unknown), Elizabeth Hanson, Hanna Kim, (unknown), (unknown), (unknown), (unknown), (unknown), Dave Witte	1
19	Interferon-γ Potentiates the Antitumor Effect of Cyclosporine-Induced Autoimmunity 1992 ·Journal of Hematotherapy ·Stephen J. Noga, L Horwitz, Hanna Kim, (unknown), Allan D. Hess	27
20	News letter 1970 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·(unknown), (unknown), (unknown), (unknown), (unknown), Hanna Kim, (unknown), (unknown), W. R. Wayne Martin, (unknown), (unknown), (unknown), (unknown), (unknown), Elizabeth A. Wilson, Kenneth H. Wong, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact